IL17A and cancer: IL-17A could activate myeloid-derived suppressor cells, recruit neutrophils, and induce the nuclear translocation of hypoxia-inducible factor-1α in cancer-associated fibroblasts to exclude CD8 + T cell infiltration [5, 7, 9, 42, 43].